Lexington, KY, United States of America

Abdulghan A Houdi

This inventor holds 1 USPTO granted patent. Top assignee: Theramax Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdulghan A Houdi. Retrieved from https://idiyas.com/inventor/abdulghan-a-houdi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Abdulghan A Houdi

Introduction

Abdulghan A Houdi is an accomplished inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the delivery of medications. His innovative approach has led to the development of a unique method for enhancing the delivery of oxybutynin.

Latest Patents

Abdulghan A Houdi holds a patent for a "Method for enhanced delivery of oxybutynin and compositions thereof." This invention provides a method for the enhancement of systemic delivery of oxybutynin by administration via the nasal route. It also includes methods of treatment comprising intranasal administration of oxybutynin. Furthermore, the present invention offers pharmaceutical compositions that comprise oxybutynin and/or pharmaceutically acceptable salts thereof. He has 1 patent to his name.

Career Highlights

Abdulghan A Houdi is currently associated with Theramax Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in his field.

Collaborations

Abdulghan collaborates with Amanda J Sherratt, contributing to the advancement of their projects and enhancing the impact of their work in the industry.

Conclusion

Abdulghan A Houdi's innovative methods for drug delivery exemplify the potential of pharmaceutical advancements. His work continues to influence the field and improve treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…